At a glance
ClinicalIndex Comparison RecordN/ACompleted· 42 enrolled
Drug / intervention
Bellafilldevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Use of Bellafill for Atrophic Acne Scar Correction in the Full Facial Area
In Brief
A clinical study evaluating Bellafill for Atrophic Acne Scarring. Completed, enrolled 42 participants across 1 site.
Detailed Summary
This is an open-label, multicenter, prospective pilot study assessing the efficacy and safety of Bellafill for correction of distensible atrophic acne scars in the full facial area. All enrolled subjects will receive initial treatment with Bellafill, as well as touch-up treatments (if necessary to achieve optimal correction). Subjects will be evaluated at Screening (Month -1), Day 0 (Baseline) Month 1, Month 4, and Month 7.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrophic Acne Scarring
CountriesUnited States
Collaboratorsethica Clinical Research Inc.
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartNov 2015
First PostedDec 2015
Primary CompletionJan 2017
TodayJul 2026
First PostedDec 30, 2015
Enrollment StartNov 18, 2015
Primary CompletionJan 27, 2017
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 10.5 years ago
Interventions
Bellafilldevice